AAAAAA
Results:
1-7
|
Results: 7
Authors:
Albers, S
Waisbren, SE
Ampola, MG
Brewster, TG
Burke, LW
Demmer, LA
Filiano, J
Greenstein, RMG
Ingham, CL
Korson, MS
Marsden, D
Schwartz, RC
Seashore, MR
Shih, VE
Levy, HL
Citation: S. Albers et al., New England Consortium: A model for medical evaluation of expanded newbornscreening with tandem mass spectrometry, J INH MET D, 24(2), 2001, pp. 303-304
Authors:
Kalser, LR
Robr, FJ
Strauss, KA
Korson, MS
Levy, HL
Citation: Lr. Kalser et al., Tyrosine supplementation in phenylketonuria: Diurnal blood tyrosine levelsand presumptive brain influx of tyrosine and other large neutral amino acids, J PEDIAT, 139(3), 2001, pp. 421-427
Authors:
Hagen, T
Korson, MS
Wolfsdorf, JI
Citation: T. Hagen et al., Urinary lactate excretion to monitor the efficacy of treatment of type I glycogen storage disease, MOL GEN MET, 70(3), 2000, pp. 189-195
Authors:
Korson, MS
Citation: Ms. Korson, Advances in newborn screening for metabolic disorders: What the pediatrician needs to know, PEDIAT ANN, 29(5), 2000, pp. 294
Authors:
Masek, BJ
Sims, KB
Bove, CM
Korson, MS
Short, P
Norman, DK
Citation: Bj. Masek et al., Quality of life assessment in adults with type 1 Gaucher disease, QUAL LIFE R, 8(3), 1999, pp. 263-268
Authors:
Hagen, T
Korson, MS
Sakamoto, M
Evans, JE
Citation: T. Hagen et al., A GC/MS/MS screening method for multiple organic acidemias from urine specimens, CLIN CHIM A, 283(1-2), 1999, pp. 77-88
Authors:
Hagen, T
Korson, MS
Citation: T. Hagen et Ms. Korson, Quantification of glutaric acid by isotope dilution mass spectrometry for patients with glutaric acidemia type I: selected ion monitoring vs. selected ion storage, CLIN CHIM A, 282(1-2), 1999, pp. 185-195
Risultati:
1-7
|